Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
National Institutes of Health · Cancer Cause and Prevention Research (93.393)
Опубликован 18 нояб. 2024 г. · Осталось примерно 3 месяца
Простыми словами
Краткое описание на русском пока недоступно; показано на английском.
The US National Institutes of Health funds preclinical and patient-based research examining how incretin-mimetic drugs (GLP-1, GIP-1, and dual agents) affect cancer risk in various populations. Multiple organisation types including nonprofits, universities, and foreign organisations may apply, with applications due by 7 January 2027.
Автоматическое краткое изложение текста донора; оригинальная формулировка приведена ниже.
Краткое описание
Исходный текст донора (английский)
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increase the risk of some, while decreasing the risk of other obesity related cancers.
Фрагмент со страницы донора. Полный текст, приложения и формы — в исходном объявлении о конкурсе.
Допустимые регионы
- Весь мир
Кто может подать заявку
- НКО / гражданское общество
- Академическое или исследовательское учреждение
- Частная компания
- Государственный орган
- Организация местного сообщества
Требования и условия
Показать требования из источника · Исходный текст донора (английский)
Applicant types: Native American tribal organizations (other than Federally recognized tribal governments); Public and State controlled institutions of higher education; Small businesses; Native American tribal governments (Federally recognized); Special district governments; Private institutions of higher education; City or township governments; Independent school districts; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; County governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Public housing authorities/Indian housing authorities; For profit organizations other than small businesses
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.